|
1
|
Xu Y, Zheng X, Qiu Y, Jia W, Wang J and
Yin S: Distinct Metabolomic Profiles of Papillary Thyroid Carcinoma
and Benign Thyroid Adenoma. J Proteome Res. 14:3315–3321. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xing M: Molecular pathogenesis and
mechanisms of thyroid cancer. Nat Rev Cancer. 13:184–199. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhou Z, Liu Y, Ma M and Chang L: Knockdown
of TRIM44 inhibits the proliferation and invasion in papillary
thyroid cancer cells through suppressing the Wnt/β-catenin
signaling pathway. Biomed Pharmacother. 96:98–103. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Han G, Gong H, Wang Y, Guo S and Liu K:
AMPK/mTOR-mediated inhibition of survivin partly contributes to
metformin-induced apoptosis in human gastric cancer cell. Cancer
Biol Ther. 16:77–87. 2015. View Article : Google Scholar :
|
|
5
|
Feng T, Li L, Ling S, Fan N, Fang M, Zhang
H, Fang X, Lan W, Hou Z, Meng Q, et al: Metformin enhances
radiation response of ECa109 cells through activation of ATM and
AMPK. Biomed Pharmacother. 69:260–266. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Qu C, Zhang W, Zheng G, Zhang Z, Yin J and
He Z: Metformin reverses multidrug resistance and
epithelial-mesenchymal transition (EMT) via activating
AMP-activated protein kinase (AMPK) in human breast cancer cells.
Mol Cell Biochem. 386:63–71. 2014. View Article : Google Scholar
|
|
7
|
Chung HH, Moon JS, Yoon JS, Lee HW and Won
KC: The relationship between metformin and cancer in patients with
type 2 diabetes. Diabetes Metab J. 37:125–131. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hall C, Stone RL, Gehlot A, Zorn KK and
Burnett AF: Use of metformin in obese women with type I endometrial
cancer is associated with a reduced incidence of cancer recurrence.
Int J Gynecol Cancer. 26:313–317. 2016. View Article : Google Scholar
|
|
9
|
Zhang X, Zhang X, Huang T, Geng J, Liu M
and Zheng J: Combination of metformin and valproic acid
synergistically induces cell cycle arrest and apoptosis in clear
cell renal cell carcinoma. Int J Clin Exp Pathol. 8:2823–2828.
2015.PubMed/NCBI
|
|
10
|
Chen X, Hu C, Zhang W, Shen Y, Wang J, Hu
F and Yu P: Metformin inhibits the proliferation, metastasis, and
cancer stem-like sphere formation in osteosarcoma MG63 cells in
vitro. Tumour Biol. 36:9873–9883. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bikas A, Jensen K, Patel A, Costello J Jr,
McDaniel D, Klubo-Gwiezdzinska J, Larin O, Hoperia V, Burman KD,
Boyle L, et al: Glucose-deprivation increases thyroid cancer cells
sensitivity to metformin. Endocr Relat Cancer. 22:919–932. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jung TW, Lee MW, Lee YJ and Kim SM:
Metformin prevents endoplasmic reticulum stress-induced apoptosis
through AMPK-PI3K-c-Jun NH2 pathway. Biochem Biophys Res Commun.
417:147–152. 2012. View Article : Google Scholar
|
|
13
|
Sun X, Liao W, Wang J, Wang P, Gao H, Wang
M, Xu C, Zhong Y and Ding Y: CSTMP induces apoptosis and
mitochondrial dysfunction in human myeloma RPMI8226 cells via
CHOP-dependent endoplasmic reticulum stress. Biomed Pharmacother.
83:776–784. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Granato M, Gilardini Montani MS, Romeo MA,
Santarelli R, Gonnella R, D'Orazi G, Faggioni A and Cirone M:
Metformin triggers apoptosis in PEL cells and alters
bortezomib-induced Unfolded Protein Response increasing its
cytotoxicity and inhibiting KSHV lytic cycle activation. Cell
Signal. 40:239–247. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
16
|
Brodowska K, Theodoropoulou S, Meyer Zu
Hörste M, Paschalis EI, Takeuchi K, Scott G, Ramsey DJ, Kiernan E,
Hoang M, Cichy J, et al: Effects of metformin on retinoblastoma
growth in vitro and in vivo. Int J Oncol. 45:2311–2324. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rico M, Baglioni M, Bondarenko M, Laluce
NC, Rozados V, André N, Carré M, Scharovsky OG and Menacho Márquez
M: Metformin and propranolol combination prevents cancer
progression and metastasis in different breast cancer models.
Oncotarget. 8:2874–2889. 2017. View Article : Google Scholar :
|
|
18
|
Ye J, Chen K, Qi L, Li R, Tang H, Zhou C
and Zhai W: Metformin suppresses hypoxia induced migration via the
HIF 1α/VEGF pathway in gallbladder cancer in vitro and in vivo.
Oncol Rep. 40:3501–3510. 2018.PubMed/NCBI
|
|
19
|
He W, He S, Wang Z, Shen H, Fang W, Zhang
Y, Qian W, Lin M, Yuan J, Wang J, et al: Astrocyte elevated
gene-1(AEG-1) induces epithelial-mesenchymal transition in lung
cancer through activating Wnt/β-catenin signaling. BMC Cancer.
15:1072015. View Article : Google Scholar
|
|
20
|
Suwei D, Liang Z, Zhimin L, Ruilei L,
Yingying Z, Zhen L, Chunlei G, Zhangchao L, Yuanbo X, Jinyan Y, et
al: NLK functions to maintain proliferation and stemness of NSCLC
and is a target of metformin. J Hematol Oncol. 8:1202015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Davies G, Lobanova L, Dawicki W, Groot G,
Gordon JR, Bowen M, Harkness T and Arnason T: Metformin inhibits
the development, and promotes the resensitization, of
treatment-resistant breast cancer. PLoS One. 12:e01871912017.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu Y, Li D, Zeng L, Wang C, Zhang L, Wang
Y, Yu Y, Liu S and Li Z: Proteasome inhibitor lactacystin enhances
cisplatin cyto-toxicity by increasing endoplasmic reticulum
stress-associated apoptosis in HeLa cells. Mol Med Rep. 11:189–195.
2015. View Article : Google Scholar
|
|
23
|
Wang J, Gao Q, Wang D, Wang Z and Hu C:
Metformin inhibits growth of lung adenocarcinoma cells by inducing
apoptosis via the mitochondria-mediated pathway. Oncol Lett.
10:1343–1349. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Reni M, Dugnani E, Cereda S, Belli C,
Balzano G, Nicoletti R, Liberati D, Pasquale V, Scavini M, Maggiora
P, et al: (Ir)relevance of metformin treatment in patients with
metastatic pancreatic cancer: An open-label, randomized phase II
trial. Clin Cancer Res. 22:1076–1085. 2016. View Article : Google Scholar
|
|
25
|
Coperchini F, Leporati P, Rotondi M and
Chiovato L: Expanding the therapeutic spectrum of metformin: From
diabetes to cancer. J Endocrinol Invest. 38:1047–1055. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cai H, Zhang Y, Han TK, Everett RS and
Thakker DR: Cation-selective transporters are critical to the
AMPK-mediated antiproliferative effects of metformin in human
breast cancer cells. Int J Cancer. 138:2281–2292. 2016. View Article : Google Scholar
|
|
27
|
Mert I, Chhina J, Allo G, Dai J, Seward S,
Carey MS, Llaurado M, Giri S, Rattan R and Munkarah AR: Synergistic
effect of MEK inhibitor and metformin combination in low grade
serous ovarian cancer. Gynecol Oncol. 146:319–326. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Su Q, Tao T, Tang L, Deng J, Darko KO,
Zhou S, Peng M, He S, Zeng Q, Chen AF, et al: Down-regulation of
PKM2 enhances anticancer efficiency of THP on bladder cancer. J
Cell Mol Med. 22:2774–2790. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mynhardt C, Damelin LH, Jivan R, Peres J,
Prince S, Veale RB and Mavri-Damelin D: Metformin-induced
alterations in nucleotide metabolism cause 5-fluorouracil
resistance but gemcitabine susceptibility in oesophageal squamous
cell carcinoma. J Cell Biochem. 119:1193–1203. 2018. View Article : Google Scholar
|
|
30
|
Tang JC, An R, Jiang YQ and Yang J:
Effects and mechanisms of metformin on the proliferation of
esophageal cancer cells in vitro and in vivo. Cancer Res Treat.
49:778–789. 2017. View Article : Google Scholar :
|
|
31
|
Zhang J, Li G, Chen Y, Fang L, Guan C, Bai
F, Ma M, Lyu J and Meng QH: Metformin inhibits tumorigenesis and
tumor growth of breast cancer cells by upregulating miR-200c but
downregu-lating AKT2 expression. J Cancer. 8:1849–1864. 2017.
View Article : Google Scholar :
|
|
32
|
Zhang J, Feng Z, Wang C, Zhou H, Liu W,
Kanchana K, Dai X, Zou P, Gu J, Cai L, et al: Curcumin derivative
WZ35 efficiently suppresses colon cancer progression through
inducing ROS production and ER stress-dependent apoptosis. Am J
Cancer Res. 7:275–288. 2017.PubMed/NCBI
|
|
33
|
Martins AS, Alves I, Helguero L, Domingues
MR and Neves BM: The Unfolded Protein Response in Homeostasis and
Modulation of Mammalian Immune Cells. Int Rev Immunol. 35:457–476.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hetz C, Chevet E and Harding HP: Targeting
the unfolded protein response in disease. Nat Rev Drug Discov.
12:703–719. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wu SM, Lin WY, Shen CC, Pan HC, Keh-Bin W,
Chen YC, Jan YJ, Lai DW, Tang SC, Tien HR, et al: Melatonin set out
to ER stress signaling thwarts epithelial mesenchymal transition
and peritoneal dissemination via calpain-mediated C/EBPβ and NFκB
cleavage. J Pineal Res. 60:142–154. 2016. View Article : Google Scholar
|
|
36
|
Fan L, Song B, Sun G, Ma T, Zhong F and
Wei W: Endoplasmic reticulum stress-induced resistance to
doxorubicin is reversed by paeonol treatment in human
hepatocellular carcinoma cells. PLoS One. 8:e626272013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
KoraMagazi A, Wang D, Yousef B, Guerram M
and Yu F: Rhein triggers apoptosis via induction of endoplasmic
reticulum stress, caspase-4 and intracellular calcium in primary
human hepatic HL-7702 cells. Biochem Biophys Res Commun.
473:230–236. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chen MC, Hsu HH, Chu YY, Cheng SF, Shen
CY, Lin YJ, Chen RJ, Viswanadha VP, Lin YM and Huang CY: Lupeol
alters ER stress-signaling pathway by downregulating ABCG2
expression to induce Oxaliplatin-resistant LoVo colorectal cancer
cell apoptosis. Environ Toxicol. 33:587–593. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lin CL, Lee CH, Chen CM, Cheng CW, Chen
PN, Ying TH and Hsieh YH: Protodioscin induces apoptosis through
ROS-mediated endoplasmic reticulum stress via the JNK/p38
activation pathways in human cervical cancer cells. Cell Physiol
Biochem. 46:322–334. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang G, Yang ZQ and Zhang K: Endoplasmic
reticulum stress response in cancer: Molecular mechanism and
therapeutic potential. Am J Transl Res. 2:65–74. 2010.PubMed/NCBI
|
|
41
|
Malhi H and Kaufman RJ: Endoplasmic
reticulum stress in liver disease. J Hepatol. 54:795–809. 2011.
View Article : Google Scholar
|
|
42
|
Cho SW, Yi KH, Han SK, Sun HJ, Kim YA, Oh
BC, Park YJ and Park DJ: Therapeutic potential of metformin in
papillary thyroid cancer in vitro and in vivo. Mol Cell Endocrinol.
393:24–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Thakur S, Daley B, Gaskins K, Vasko VV,
Boufraqech M, Patel D, Sourbier C, Reece J, Cheng SY, Kebebew E, et
al: Metformin targets mitochondrial glycerophosphate dehydrogenase
to control rate of oxidative phosphorylation and growth of thyroid
cancer in vitro and in vivo. Clin Cancer Res. 24:4030–4043. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Morales DR and Morris AD: Metformin in
cancer treatment and prevention. Annu Rev Med. 66:17–29. 2015.
View Article : Google Scholar
|
|
45
|
Yang J, Wei J, Wu Y, Wang Z, Guo Y, Lee P
and Li X: Metformin induces ER stress-dependent apoptosis through
miR-708-5p/NNAT pathway in prostate cancer. Oncogenesis.
4:e1582015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wang GY, Bi YG, Liu XD, Zhao Y, Han JF,
Wei M and Zhang QY: Autophagy was involved in the protective effect
of metformin on hyperglycemia-induced cardiomyocyte apoptosis and
Connexin43 downregulation in H9c2 cells. Int J Med Sci. 14:698–704.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Xiao Z, Gaertner S, Morresi-Hauf A, Genzel
R, Duell T, Ullrich A and Knyazev PG: Metformin triggers autophagy
to attenuate drug-induced apoptosis in NSCLC cells, with minor
effects on tumors of diabetic patients. Neoplasia. 19:385–395.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Li J, Gui Y, Ren J, Liu X, Feng Y, Zeng Z,
He W, Yang J and Dai C: Metformin protects against
cisplatin-induced tubular cell apoptosis and acute kidney injury
via AMPKα-regulated autophagy induction. Sci Rep. 6:239752016.
View Article : Google Scholar
|
